|
1.
|
Neil JC and Cameron ER: Retroviral
insertion sites and cancer: fountain of all knowledge? Cancer Cell.
2:253–255. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Tamir A, Howard J, Higgins RR, Li Y,
Berger L, Zacksenhaus E, Reis M and Ben-David Y: Fli-1, an
Ets-related transcription factor, regulates erythropoietin-induced
erythroid proliferation and differentiation: evidence for direct
transcriptional repression of the Rb gene during differentiation.
Mol Cell Biol. 19:4452–4464. 1999.
|
|
3.
|
Ben-David Y, Prideaux VR, Chow V,
Benchimol S and Bernstein A: Inactivation of the p53 oncogene by
internal deletion or retroviral integration in erythroleukemic cell
lines induced by Friend leukemia virus. Oncogene. 3:179–185.
1988.PubMed/NCBI
|
|
4.
|
Li YJ, Higgins RR, Pak BJ, Shivdasani RA,
Ney PA, Archer M and Ben-David Y: p45(NFE2) is a negative regulator
of erythroid proliferation which contributes to the progression of
Friend virus-induced erythroleukemias. Mol Cell Biol. 21:73–80.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cui JW, Li YJ, Sarkar A, Brown J, Tan YH,
Premyslova M, Michaud C, Iscove N, Wang GJ and Ben-David Y:
Retroviral insertional activation of the Fli-3 locus in
erythroleukemias encoding a cluster of microRNAs that convert
Epo-induced differentiation to proliferation. Blood. 110:2631–2640.
2007.PubMed/NCBI
|
|
6.
|
Shaked Y, Cervi D, Neuman M, Pak B, Kerbel
RS and Ben-David Y: Splenic microenvironment is a source of
angiogenesis/inflammatory mediators accelerating the
extra-medullary expansion of murine erythroleukemic cells. Blood.
105:4500–4507. 2005.
|
|
7.
|
Oliff AI, Hager GL, Chang GH, Scolnick EM,
Chan HW and Lowy DR: Transfection of molecularly cloned Friend
murine leukemia virus DNA yields a highly leukemogenic
helper-independent type C virus. J Virol. 33:475–486.
1980.PubMed/NCBI
|
|
8.
|
Moreau-Gachelin F, Tavitian A and
Tambourin P: Spi-1 is a putative oncongene in virally induced
murine erythroleukemias. Nature. 331:277–280. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ben-David Y, Giddens EG, Letwin K and
Bernstein A: Erythroleukemia induction by Friend murine leukemia
virus: insertional activation of a new member of the ets gene
family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–918.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Wolff L: Myb-induced transformation. Crit
Rev Oncog. 7:245–260. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Moreau-Gachelin F, Wendling F, Molina T,
Denis N, Titeux M, Grimber G, Briand P, Vainchenker W and Tavitian
A: Spi-1/PU. 1 transgenic mice develop multistep erythroleukemias.
Mol Cell Biol. 16:2453–2463. 1996.PubMed/NCBI
|
|
12.
|
Hasegawa M, Yamaguchi S, Aizawa S, Ikeda
H, Tatsumi K, Noda Y, Hirokawa K and Kitagawa M: Resistance against
Friend leukemia virus-induced leukemogenesis in DNA-dependent
protein kinase (DNA-PK)-deficient scid mice associated with
defective viral integration at the Spi-1 and Fli-1
site. Leukemia Res. 29:933–942. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Daniel R, Katz RA and Skalka AM: A role
for DNA-PK in retroviral DNA integration. Science. 284:644–647.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Daniel R, Katz RA, Merkel G, Hittle JC,
Yen TJ and Skalka AM: Wortmannin potentiates integrase-mediated
killing of lymphocytes and reduces the efficiency of stable
transduction by retroviruses. Mol Cell Biol. 21:1164–1172. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wurtele H, Little KCE and Chartrand P:
Illegitimate DNA integration in mammalian cells. Gene Ther.
10:1791–1799. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Mayne LV, Jones T, Dean SW, Harcourt SA,
Lowe JE, Priestley A, Steingrimsdottir H, Sykes H, Green HL and
Lehmann R: SV40-transformed normal and DNA-repair-deficient human
fibroblasts can be transfected with high frequency but retain only
limited amounts of integrated DNA. Gene. 66:65–76. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bartholomew C and Ihle JN: Retroviral
insertions 90 kilobases proximal to the Evi-1 myeloid transforming
gene activate transcription from the normal promoter. Mol Cell
Biol. 11:1820–1828. 1991.PubMed/NCBI
|
|
18.
|
Lazo PA, Lee JS and Tsichlis PN:
Long-distance activation of the Myc protooncogene by
provirus insertion in Mlvi1 or Mlvi4 in rat T-cell
lymphomas. Proc Natl Acad Sci USA. 87:170–173. 1990.
|
|
19.
|
Bedigian HG, Johnson DA, Jenkins NA,
Copeland NG and Evans R: Spontaneous and induced leukemias of
myeloid origin in recombinant inbred BXH mice. J Virol. 51:586–594.
1984.PubMed/NCBI
|
|
20.
|
Largaespada DL, Brannan CI, Jenkins NA and
Copeland NG: Nf1 deficiency causes Ras-mediated
granulocyte/macrophage stimulating factor hypersensitivity and
chronic myeloid leukemia. Nat Genet. 12:137–143. 1996. View Article : Google Scholar
|
|
21.
|
Blaydes SM, Kogan SC, Truong BH, Gilbert
DJ, Jenkins NA, Copeland NG, Largaespada DA and Brannan CI:
Retroviral integration at the Epi1 locus cooperates with the
Nf1 gene loss in the progression to acute myeloid leukemia.
J Virol. 75:9427–9434. 2001.PubMed/NCBI
|
|
22.
|
Shimizu S, Suzukawa K, Kodera T, Nagasawa
T, Abe T, Taniwaki M, Yagasaki F, Tanaka H, Fujisawa S, Johansson
B, Ahlgren T, Yokota J and Morishita K: Identification of
breakpoint cluster regions at 1p36.3 and 3q21 in hematologic
malignancies with t(1;3)(p36;q21). Genes Chromosomes Cancer.
27:229–238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Mochizuki N, Shimizu S, Nagasawa T, Tanaka
H, Taniwaki M, Yokota J and Morishita K: A novel gene, MEL1, mapped
to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is
transcriptionally activated in t(1;3)(p36;q21)-positive leukemia
cells. Blood. 96:3209–3214. 2000.PubMed/NCBI
|
|
24.
|
Sakai I, Tamura T, Narumi H, Uchida N,
Yakushijin Y, Hato T, Fujita S and Yasukawa M: Novel RUNX1-PRDM16
fusion transcripts in a patient with acute myeloid leukemia showing
t(1;21) (p36;q22). Genes Chromosomes Cancer. 44:265–270. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Nishikata I, Sasaki H, Iga M, Tateno Y,
Imayoshi S, Asou N, Nakamura T and Morishita K: A novel EVI1 gene
family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in
t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid
differentiation. Blood. 102:3323–3332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Xiao Z, Zhang M, Liu X, Zhang Y, Yang L
and Hao Y: MEL1S, not MEL1, is overexpressed in myelodysplastic
syndrome patients with t(1;3)(p36;q21). Leuk Res. 30:332–334. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Du Y, Jenkins NA and Copeland NG:
Insertional mutagenesis identifies genes that promote the
immortalization of primary bone marrow progenitor cells. Blood.
106:3932–3939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Steidl U, Steidl C, Ebralidze A, Chapuy B,
Han HJ, Will B, Rosenbauer F, Becker A, Wagner K, Koschmieder S,
Kobayashi S, Costa DB, Schulz T, O’Brien KB, Verhaak RGW,
Griesinger F and Tenen DG: A distal single nucleotide polymorphism
alters long-range regulation of the PU.1 gene in acute
myeloid leukemia. J Clin Invest. 117:2611–2620. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Tenen DG: Disruption of differentiation in
human cancer: AML shows the way. Nat Rev Cancer. 3:89–101. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Iwasaki H, Somoza C, Shigematsu H, Duprez
EA, Iwasaki-Arai J, Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram
T, Fenyus ML, Elf S, Chan S, Kastner P, Huettner CS, Murray R,
Tenen DG and Akashi K: Distinctive and indispensable roles of PU.1
in maintenance of hematopoietic stem cells and their
differentiation. Blood. 106:1590–1600. 2005. View Article : Google Scholar : PubMed/NCBI
|
